Fluidr
about   tools   help   Y   Q   a         b   n   l
User / GE Healthcare / GE Healthcare to Acquire Clarient Inc.
785 items
Estrogen receptor and progesterone receptor over-expression helps detect whether a patient is eligible for Tamoxifen® therapy for breast cancer
Popularity
  • Views: 1230
  • Comments: 0
  • Favorites: 1
Dates
  • Taken: Oct 14, 2010
  • Uploaded: Oct 22, 2010
  • Updated: Apr 17, 2024